You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Ultra-High Temperature Thermoelectrics

    SBC: EM-TECH, INC.            Topic: N151068

    Hypersonic vehicles need compact, high temperature capable power sources since batteries are not sufficiently compact and require insulation. A thermoelectric (TE) energy-harvesting system converts thermal energy into electricity by taking advantage of the temperature difference between two surfaces. The objective of this effort is to increase the temperature limits of current TE materials from ap ...

    SBIR Phase II 2017 Department of DefenseNavy
  2. An Intraoperative Guidance Platform for Radio Frequency Ablation

    SBC: NE Scientific, LLC            Topic: 102

    Project Summary: The objective of this proposed research program is to develop a platform for planning and guidance during Radio Frequency Ablation (RFA). RFA is a thermally mediated ablation technique, where an applicator carrying one electrode is inserted into tumors percutaneously (or via laparoscopy, or open surgical approaches). Radio Frequency (RF) energy is applied, denaturating and coagula ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  3. Topside Optical Processing for Global Unmanned Navy (TOPGUN)

    SBC: Charles River Analytics, Inc.            Topic: OSD12HS3

    Subsequent Phase II Proposal, extension of Phase I contract N00014-13-P-1152.Under the ACTUV program, DARPA developed a strategically critical autonomous anti-submarine warfare vessel, called Sea Hunter. One key to Sea Hunter’s success is an ability to avoid collisions with manned vessels by following the International Regulations for Preventing Collisions at Sea (COLREGS). However, autonomous C ...

    SBIR Phase II 2017 Department of DefenseNavy
  4. Marketing Strategic Plan and Distribution Logistics for Sanaria PfSPZ Vaccine against Malaria.

    SBC: SANARIA INC.            Topic: NIAID

    ABSTRACT The development of Sanaria s Plasmodium falciparumPfsporozoiteSPZbased vaccines is receiving overwhelming global support after the publication inin Science of clinical data showingprotection against controlled human malaria infectionCHMIfollowing intravenous administration ofdoses of SanariaPfSPZ Vaccinecomposed of purifiedasepticradiation attenuatedcryopreserved PfSPZ meeting all regulat ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  5. NDI System for Quantification of Subsurface Residual Stress in the Laboratory

    SBC: Radiation Monitoring Devices, Inc.            Topic: N152091

    The goal of the proposed research is to develop a non-destructive method for subsurface residual stress measurement in turbo-machinery components. Neutron diffraction techniques have a proven ability to determine residual stresses at significant depths, however implementation of these techniques has been limited to specialized facilities such as the High Flux Isotope Reactor (HFIR) neutron at Oak ...

    SBIR Phase II 2017 Department of DefenseNavy
  6. Binary code Randomization for Attack Sensitive Software (BRASS)

    SBC: INTELLIGENT AUTOMATION, INC.            Topic: N152120

    Most of the existing efforts fighting against cyber-attacks in critical cyber systems are focused on achieving resiliency and survivability. However, there are specific mission requirements for certain types of critical cyber systems that demand for the mission software to fail/crash, as soon as possible, when cyber-attack is successful and a program control is lost, rather than to operate in some ...

    SBIR Phase II 2017 Department of DefenseNavy
  7. Improved long-term biocompatibility of coronary stents by plasma coating process

    SBC: NANOVA INC.            Topic: NHLBI

    Improved long term biocompatibility of coronary stents by plasma coating process Abstract Drug eluting stentsDEShave been widely used to treat patients of coronary heart diseaseCHDdue to their better ability to control restenosis than bare metal stentsBMSHoweverthere is a high risk of late in stent thrombosis associated with DES after implantation in patientswhich could lead to fatal heart attack ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  8. Antithrombotic Therapy with No Bleeding Risk for PCI

    SBC: APT THERAPEUTICS, INC.            Topic: y

    Adjunctive antithrombotic treatment with dual antiplatelet therapyaspirinP Yantagonistplus anticoagulantheparin or bivalirudinis a guideline mandated for percutaneous coronaryinterventionPCIpatientsDespite aggressive antithrombotic therapyhowevermyocardialperfusion after PCI remains inadequate in many patientsReocclusion from recurrent thrombosiscontinues to occurand dose limiting bleeding occurs ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  9. Validation of an In Vitro Human Airway Model for Regulatory Toxicity Testing

    SBC: Mattek Corporation            Topic: NIEHS

    Results of Phase II research indicate that formal validation of the EpiAirwayin vitro human bronchial tissue model for predicting toxicity of inhaled chemicals is an attainable goalThe proposed Phase IIB cooperative agreement project is intended to realize this goal by conducting formal ring trial validation studies that will be submitted to regulatory agencies and the Organization for Economic Co ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
  10. Novel non-invasive antigen detection assay for the diagnosis of active visceral leishmaniasis and to monitor the therapy efficacy of this disease

    SBC: DETECTOGEN INC.            Topic: NIAID

    ABSTRACTThe overall goal of this Phase II project is to validate novel leishmanial protein biomarkers for development of a non invasive urine based assay to diagnose active visceral leishmaniasisVLand to monitor the therapeutic efficacy of this serious diseaseVL is endemic incountriesaffectspeople a year and kills more thanof them children under ageVLalso known as kala azaris caused by parasites o ...

    SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government